EPHB4 and vein of Galen aneurysm: A genetic background has been recently identified in VGAM patients, including mutations of RASA1 (RASp21 Protein Activator 1) and EPHB4 (Ephrin type-B receptor 4), genes encoding proteins involved in vascular development (3–5).